Skip to content

Zilver PTX G38487Recalls & reported problems

Cook Ireland Ltd · Zilver PTX, Drug-Eluting Peripheral Stent · Class 3 · Implant

All models of Zilver PTX (28)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
6
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 6 adverse event reports that list this exact device (DI 10827002384870), received between May 29, 2017 and Mar 26, 2025 — classified as 1 injury, 5 malfunctions.

The most frequently reported specific device problem is “Activation Failure” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 1 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 1 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Activation Failure1
  • Activation, Positioning or Separation Problem1
  • Adverse Event Without Identified Device or Use Problem1
  • Break1
  • Device Expiration Issue1
  • Improper or Incorrect Procedure or Method1
  • Material Deformation1
  • Off-Label Use1

Patient problems

  • No Clinical Signs, Symptoms or Conditions2
  • No Known Impact Or Consequence To Patient2
  • No Consequences Or Impact To Patient1
  • Thrombosis/Thrombus1

Recent adverse event reports

The 6 most recent of 6 reports, in the reporter's own words as published by the FDA.

  • InjuryMar 26, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    ACCORDING TO THE INITIAL REPORTER: ON THURSDAY AFTERNOON (2/27) DURING ANGIO AND LOWER EXTREMITY INTERVENTION, THE PHYSICIAN DEPLOYED FOUR ZILVER PTX STENTS IN AN SFA (TWO 7X140 PTX STENTS G38491 AND ONE 7X60 STENT G38487 IN PROXIMAL SFA ALONG WITH ONE 6X140 PTX STENT G38483) IN DISTAL SFA. AFTER POST DILATING WITH A 5X220 MUSTANG BALLOON, DR WAS PLEASED WITH THE FINAL RUN IMAGING (SEE ATTACHED). HOWEVER, SHE LET US KNOW YESTERDAY AFTERNOON THAT THE PATIENT THROMBOSED, POSSIBLY WITHIN THE STENTED SEGMENT. DR SAID IT¿S STRANGE THAT THE STENTS THROMBOSED BECAUSE HER REST PAIN WAS HEALED, AND SHE FEELS A LOT BETTER. THEY LOADED PLAVIX IN RECOVERY, AND SHE HAD BEEN ON ASA PRIOR TO THE CASE, SO THERE WAS NO LAPSE IN ANTI-PLATELET THERAPY. THEY JUST GOT A DUPLEX ULTRASOUND IN FOLLOW UP SO SHE¿S BRINGING THE PATIENT IN LATER TODAY FOR EITHER THROMBECTOMY OR BYPASS, BASED ON WHAT IS FOUND UNDER FLUORO. SHE BELIEVES THE LONG-STENTED SEGMENT, COMBINED WITH UNTREATED HYPOTENSION COULD BE THE SOURCE OF THE THROMBOSIS. SHE ALSO EXPRESSED CONCERNS OVER POTENTIAL FOR THUMBWHEEL DEPLOYMENT STENTS TO JUMP AND PREFERS PIN-AND-PULL FOR MORE PRECISION. THE PATIENT THROMBOSED, POSSIBLY WITHIN THE STENT

    Patient problems: Thrombosis/Thrombus

    MAUDE report 21701863 ↗
  • MalfunctionDec 15, 2023Off-Label Use; Off-Label Use

    THE INTENDED TARGET SITE FOR THE DEVICE WAS THE RIGHT COMMON ILIAC; HOWEVER, THE DEVICE LANDED FURTHER UP INTO THE AORTA AS THE USER BELIEVED IT WAS NOT WELL IMPOSED. THE USER WANTED TO USE A CUFF TO RECTIFY BUT THE STENT WAS VERY MOBILE SO THEY ELECTED TO LEAVE IT ALONE. IT APPEARED IT WOULD MIGRATE NORTH TOWARD THE RENAL SO THEY ELECTED TO NOT INTERVENE. IT IS IMPORTANT TO NOTE THE DEVICE WAS BEING USED OFF LABEL. PATIENT OUTCOME: NA. PATIENT/EVENT INFO - NOTES: SHEATH USED . WIRE GUIDE. IPSILATERAL . RIGHT COM ILIAC - OFF LABEL.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 18335069 ↗
  • MalfunctionSep 13, 2022Break; Material Deformation; Activation Failure; Break; Material Deformation; Activation Failure

    AS INITIALLY REPORTED TO CUSTOMER RELATIONS: A PATIENT OF UNSPECIFIED GENDER AND AGE UNDERWENT AN UNSPECIFIED PROCEDURE IN WHICH THE ZILVER PTX STENT WAS USED. THE PTX STENT DIDN'T DEPLOY CORRECTLY.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 15409488 ↗
  • MalfunctionApr 2, 2020Improper or Incorrect Procedure or Method; Improper or Incorrect Procedure or Method

    AS INITIALLY REPORTED TO CUSTOMER RELATIONS VIA PHONE DISCUSSION WITH THE DISTRICT MANAGER: A (B)(6) PATIENT, WHO PREVIOUSLY HAD A ZILVER PTX STENT PLACED, UNDERWENT A LEFT SFA PROCEDURE IN WHICH A ZILVER PTX 35 DRUG-ELUTING STENT, G38487, WAS TO BE PLACED TO EXTEND BELOW THE PREVIOUS STENT AS THE DISEASE HAD SPREAD. THE PHYSICIAN STARTED TO DEPLOY THE STENT AND IT GOT STUCK HALF WAY THROUGH DEPLOYMENT; THE THUMB WHEEL DID NOT MOVE. PHYSICIAN THEN TRIED THE RED BUTTON BUT THE STENT WOULD NOT MOVE; PUSHED ON THE THUMB WHEEL FIRMLY AND IT JUMPED AND THE REST OF THE STENT DEPLOYED. PER PHYSICIAN CONFIRMATION THE STENT HAD DEPLOYED IN TARGETED LOCATION WELL ENOUGH. AN ADDITIONAL THREE (3) OF THE SAME ZILVER STENTS, G38487, WERE DEPLOYED TO COVER THE DISEASED PART THAT HAD SPREAD AND THESE STENTS DEPLOYED WITH NO DIFFICULTY.

    Patient problems: No Known Impact Or Consequence To Patient

    MAUDE report 9917091 ↗
  • MalfunctionOct 24, 2019Activation, Positioning or Separation Problem; Activation, Positioning or Separation Problem

    REPORTED BY THE DM VIA PHONE CALL- DURING THE PROCEDURE BOTH STENTS DID NOT DEPLOY EVENLY. THEY DEPLOYED FULLY, BUT WERE CRUNCHED UP. BOTH STENTS ARE IMPLANTED IN THE PATIENT. FDA MDR REPORTING REQUIRED: EVENT IS FDA MDR REPORTABLE BASED ON THE DEVICE MALFUNCTION REPORTING PRECEDENCE FOR THIS DEVICE FAMILY FOR THE ISSUE OF 'STENT SHORTENING OR COMPRESSION DURING DEPLOYMENT' . NO ADVERSE EFFECTS TO THE PATIENT HAVE BEEN REPORTED AS OCCURRING.

    Patient problems: No Known Impact Or Consequence To Patient

    MAUDE report 9231449 ↗
  • MalfunctionMay 29, 2017Device Expiration Issue; Device Expiration Issue

    AFTER IMPLANTING THE STENT, THE CUSTOMER REALIZED THAT THE DEVICE HAD EXPIRED. THE REP WAS NOT PRESENT DURING THE SELECTION OF THIS DEVICE OR DURING DEPLOYMENT. THE STENT WAS PLACED SUCCESSFULLY AND NO PROBLEMS WERE OBSERVED.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 6596478 ↗

Other Stent, superficial femoral artery, drug-eluting devices

All Stent, superficial femoral artery, drug-eluting devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page